RXO (NYSE:RXO - Free Report) had its target price lowered by Susquehanna from $18.00 to $13.00 in a report published on Wednesday morning,Benzinga reports. Susquehanna currently has a negative rating on the stock.
A number of other research firms have also recently issued reports on RXO. The Goldman Sachs Group cut their price objective on shares of RXO from $28.00 to $24.00 and set a "neutral" rating on the stock in a research report on Thursday, February 6th. Barclays cut their price target on RXO from $32.00 to $30.00 and set an "overweight" rating on the stock in a report on Friday, January 17th. Deutsche Bank Aktiengesellschaft started coverage on RXO in a report on Friday, March 7th. They set a "hold" rating and a $19.00 price objective for the company. Stifel Nicolaus cut their target price on RXO from $27.00 to $24.00 and set a "hold" rating on the stock in a report on Thursday, February 6th. Finally, Jefferies Financial Group lowered their price objective on shares of RXO from $33.00 to $30.00 and set a "buy" rating on the stock in a report on Friday, January 10th. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $25.33.
Get Our Latest Stock Report on RXO
RXO Trading Down 2.5 %
Shares of RXO stock traded down $0.49 on Wednesday, hitting $18.86. 756,611 shares of the company's stock traded hands, compared to its average volume of 1,036,859. The company has a fifty day moving average of $21.31 and a two-hundred day moving average of $25.19. RXO has a one year low of $17.50 and a one year high of $32.82. The company has a market capitalization of $3.08 billion, a price-to-earnings ratio of -8.90, a price-to-earnings-growth ratio of 4.55 and a beta of 1.67. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.26 and a quick ratio of 1.33.
RXO (NYSE:RXO - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.06 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.06. RXO had a positive return on equity of 1.53% and a negative net margin of 6.26%. As a group, sell-side analysts expect that RXO will post 0.31 earnings per share for the current year.
Institutional Investors Weigh In On RXO
A number of hedge funds have recently made changes to their positions in RXO. Wilmington Savings Fund Society FSB purchased a new position in RXO in the third quarter valued at about $28,000. Blue Trust Inc. grew its holdings in RXO by 79.7% during the fourth quarter. Blue Trust Inc. now owns 1,150 shares of the company's stock valued at $27,000 after purchasing an additional 510 shares during the period. Smartleaf Asset Management LLC raised its stake in shares of RXO by 228.4% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,248 shares of the company's stock valued at $30,000 after buying an additional 868 shares during the period. Nomura Asset Management Co. Ltd. lifted its position in shares of RXO by 68.7% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company's stock valued at $39,000 after buying an additional 570 shares during the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. grew its stake in shares of RXO by 407.0% during the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,800 shares of the company's stock worth $43,000 after acquiring an additional 1,445 shares during the period. 92.73% of the stock is currently owned by institutional investors.
About RXO
(
Get Free Report)
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
Read More

Before you consider RXO, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RXO wasn't on the list.
While RXO currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.